Sonify Biosciences is an early stage life sciences company developing novel ultrasound-based hyperthermia equipment.
Sonify Policy for Sponsored Research
Sonify Biosciences is active in external research collaborations with both academic and private research organizations. The policy of Sonify Biosciences is to limit the amount of indirect costs associated with any research funding it provides to any research organizations to 10% through Sponsored Research Agreements, Collaborative Research Agreements, or other research related agreements.
Sonify shall not agree to overhead costs, indirect costs or other research associated costs above ten percent (10%) of the cost of the contracted research amount.